STRIDE事后分析:支架内或移植物内与自体血管血栓机械抽吸效果相似
STRIDE单臂研究纳入119例下肢急性肢体缺血患者,均一线使用Indigo机械抽吸系统。事后分析比较支架内血栓29例、移植物内血栓19例与自体血管血栓71例,主要终点30天保肢及次要终点均无显著差异;支架内血栓与30天内再治疗风险升高相关。
要点
- 支架内或移植物内血栓一线机械抽吸的30天保肢与技术成功率与自体血管血栓相近。
- 移植物内血栓组过夜辅助溶栓使用率高于自体血管组(52.6%对11.3%,P<.001)。
- 美国患者校正年龄性别后,支架内血栓与30天内再治疗相关(HR 3.8,95%CI 1.1-13.3,P=.040)。
核心结论
- 支架内或移植物内血栓虽可能治疗更具挑战,但一线Indigo机械抽吸仍获高技术成功率与高30天保肢率,与自体血管组结果相似。
- 支架内与移植物内组均未发生器械相关严重不良事件。
- 支架内血栓与再治疗风险升高相关,该风险与器械或操作无关,可能源于支架置入的已知并发症。
研究设计与样本
- STRIDE为前瞻性单臂研究,在美国和欧洲16个中心纳入119例下肢急性肢体缺血成人患者,均一线接受Indigo抽吸系统治疗。
- 本分析为STRIDE事后分析,比较支架内血栓组(29例)、移植物内血栓组(19例)与自体血管血栓组(71例)的结局。
- 主要终点为术后30天目标肢体保肢,次要终点包括器械相关严重不良事件、技术成功(术后TIMI血流2/3级)和30天通畅率。
主要发现
- 支架内与自体血管血栓比较、移植物内与自体血管血栓比较,主要和次要终点均无显著差异。
- 过夜辅助溶栓使用率在移植物内组为52.6%(10/19),自体血管组为11.3%(8/71),P<.001。
- 美国患者校正年龄和性别后,支架内血栓与30天内再治疗时间相关(HR 3.8,95%CI 1.1-13.3,P=.040)。
关键数值与推荐
- 技术成功定义为术后TIMI血流2/3级。
- 主要终点为术后30天目标肢体保肢。
- 移植物内组过夜辅助溶栓使用率52.6%(10/19)对自体血管组11.3%(8/71),P<.001。
- 支架内血栓再治疗风险HR 3.8(95%CI 1.1-13.3,P=.040),为美国患者校正年龄和性别后的多变量Cox模型结果。
临床怎么用
- 对下肢急性肢体缺血合并支架内或移植物内急性血栓者,可考虑一线使用Indigo机械抽吸,预期与技术成功和30天保肢率良好相关。
- 支架内血栓患者需警惕30天内再治疗风险升高,应加强随访。
- 移植物内血栓患者更常需过夜辅助溶栓,临床应提前评估与安排。
局限性
- 本分析为单臂研究的事后亚组分析,非随机对照,组间比较存在混杂可能。
- 原文未报告各亚组基线差异、随访时长及再治疗具体原因等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lower extremity acute limb ischemia (LE-ALI) is a severe form of peripheral artery disease associated with high morbidity and mortality rates. Thrombus in previously placed stents or grafts may present treatment challenges when compared with treatment of thrombus in native vessels, and data evaluating first-line treatment with mechanical aspiration thrombectomy are lacking. This post hoc analysis of STRIDE (A study of patients with lower extremity acute limb ischemia to remove thrombus with the Indigo Aspiration System) examines outcomes for first-line mechanical aspiration thrombectomy with the Indigo Aspiration System for LE-ALI in patients with either in-stent or in-graft thrombosis as compared with native vessel thrombosis. METHODS: STRIDE was a prospective, single-arm study that enrolled 119 adult patients across 16 sites in the United States and Europe who were treated first-line with the Indigo Aspiration System for LE-ALI. The primary outcome was target limb salvage at 30 days post procedure. Secondary outcomes included device-related serious adverse events, technical success (postprocedure Thrombolysis in Myocardial Infarction flow grades 2/3), and patency at 30 days. Outcomes for the in-stent thrombosis group vs the native vessel thrombosis group, and for the in-graft thrombosis group vs the native vessel thrombosis group, were compared. RESULTS: Of the 119 STRIDE patients, 29 had in-stent thrombosis, 19 had in-graft thrombosis, and 71 had native vessel thrombosis. For both the in-stent vs native vessel thrombosis and the in-graft vs native vessel thrombosis group comparisons, there were no significant differences for any of the primary or secondary outcomes. Overnight adjunctive thrombolytics use was higher for the in-graft vs native vessel groups (52.6% [10/19]) and 11.3% [8/71], respectively; P < .001). In a combined multivariate Cox model, when adjusted for age and sex among US patients, in-stent thrombosis was associated with time to retreatment within 30 days (hazard ratio, 3.8; 95% confidence interval, 1.1-13.3; P = .040). CONCLUSIONS: Although in-stent and in-graft thrombosis may represent more challenging treatment settings for LE-ALI, high technical success and high target limb salvage rates at 30 days were observed for both groups, similar to the favorable results seen in the native vessel group. Additionally, there were no device-related serious adverse events in either the in-stent or in-graft groups. In-stent thrombosis is associated with an increased risk of retreatment, which is unrelated to the device or procedure and may be expected owing to known complications of stenting. This STRIDE subgroup analysis shows that first-line mechanical aspiration thrombectomy using Indigo is safe and effective for LE-ALI patients in presentations of acute thrombosis in a stent or graft.
引用
- Maldonado TS, Powell A, Wendorff H, et al. STRIDE study post hoc analysis shows first-line mechanical aspiration thrombectomy for either in-stent or in-graft versus native vessel thrombosis in lower extremity acute limb ischemia yields similar outcomes. J Vasc Surg. 2025. PMID: 41177276. doi:10.1016/j.jvs.2025.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。